Safety considerations of recombinant protein therapy: introductory comments

Clin Immunol Immunopathol. 1997 Apr;83(1):1-4. doi: 10.1006/clin.1996.4301.
No abstract available

Publication types

  • Comment
  • Review

MeSH terms

  • Animals
  • Antibody Formation
  • Humans
  • Interleukin-3 / immunology
  • Recombinant Proteins / standards*
  • Recombinant Proteins / therapeutic use*

Substances

  • Interleukin-3
  • Recombinant Proteins